A person required to undergo a program of hormone or antiandrogen, such as medroxyprogesterone acetate, treatment under ORS 144.625 shall pay all costs of the program directly to the agency or organization administering the treatment program. [1999 c.435 §3]
Note: See note under 144.625.
Section: Previous 144.613 144.615 144.617 144.620 144.622 144.625 144.627 144.629 144.631 144.635 144.637 144.639 144.640 144.641 144.642 NextLast modified: August 7, 2008